CV Sciences, Inc.
No SEC Form 4 filings for $CVSI in the last 30 days.
See all $CVSI insider activity →CV Sciences (OTCQB:CVSI) launched PlusHLTH.com, a direct-to-consumer site for its +PlusHLTH non-cannabinoid product line, expanding beyond its PlusCBDOil.com focus on hemp-derived CBD. The company says the site supports its “Health Intelligence” approach with science-backed education and plans to add new formulations and delivery formats.
CV Sciences, Inc. (OTCQB: CVSI) said it will report second-quarter 2026 results for the quarter ended June 30, 2026 after the market closes on Aug. 13, 2026. The company will host a conference call and webcast at 1:30 p.m. PT the same day, with a replay available through Aug. 20.
Over the past 7 days, alphai's AI scored 2 news stories mentioning CVSI (CV Sciences, Inc.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.
Recent CVSI coverage spans financial news and earnings.
A new DTC brand site supports the company’s shift beyond cannabinoids, but the release provides no financial targets or measurable KPIs.
This is a scheduled earnings-release setup for CVSI, creating a near-term catalyst window around Aug. 13.
alphai scores every news story that mentions CVSI with an AI model for sentiment and relevance, and aggregates insider trades from CV Sciences, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CV Sciences (OTCQB:CVSI) launched PlusHLTH.com, a direct-to-consumer site for its +PlusHLTH non-cannabinoid product line, expanding beyond its PlusCBDOil.com focus on hemp-derived CBD. The company says the site supports its “Health Intelligence” approach with science-backed education and plans to add new formulations and delivery formats.
2 min readCV Sciences, Inc. (OTCQB: CVSI) said it will report second-quarter 2026 results for the quarter ended June 30, 2026 after the market closes on Aug. 13, 2026. The company will host a conference call and webcast at 1:30 p.m. PT the same day, with a replay available through Aug. 20.
2 min read